8-K current report · filed Oct 21, 2026

Elevance Health (ELV) 8-K Current Report: October 21, 2026

Item 2.02Item EX-99.1ELV overview

Short answer

Elevance Health (ELV) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Elevance Health announced financial results for the quarter ended September 30, 2026.

Elevance Health 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Elevance Health announced financial results for the quarter ended September 30, 2026
  • Full earnings details, including key metrics and management commentary, appear in Exhibit 99.1

Item EX-99.1 · Exhibit EX-99.1

  • 3Q operating revenue $50.4B, up 0.7%, while GAAP diluted EPS rose 17.9% to $6.27
  • Adjusted diluted EPS $6.99, supported by a $1.85-per-share net non-operating benefit
  • FY 2026 guidance raised to at least $22.00 GAAP EPS and $29.00 adjusted EPS
  • Health Benefits margin fell to 1.0% as membership declined 487,000 year over year
  • Carelon operating gain increased 17% to $0.9B, offsetting weaker Health Benefits profitability

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Elevance Health 8-K filings

Get the next ELV 8-K as it lands

Follow ELV for push alerts, or ask the research agent what this filing means.